September 22, 2026
Labs & Dx: Draft CY27 Rate Winners & Losers
CMS’s preliminary CY27 rates for lab codes targeted through the next phase of adjustments under the Protecting Access to Medicare Act (PAMA), released last night, appear largely consistent with the ~$100 M risk projections previously…
January 20, 2026
Tools, Dx, & Labs: Lawmakers Come Through
The bipartisan, bicameral FY26 HHS appropriations bill text released this morning is largely consistent with our expectations, with incremental upside for life science tools (LST), diagnostics, and clinical labs. More specifically, the legislation – which…